DEPDC1, a glycolysis-related gene, has been shown to promote the progression of oral squamous cell carcinoma (OSCC), predict the progression and prognosis of RCC, and serve as a predictor of prognostic risk in hepatocellular carcinoma (HCC) [10, 11, 27]. This evidence concerns the gene DEPDC1 and hepatocellular carcinoma.